HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Free Cash Flow (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Free Cash Flow came in at $96.5 million in Q2 2021, up 200.69% year-over-year from $32.1 million in Q2 2020, and up 692.26% quarter-over-quarter from -$16.3 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Free Cash Flow (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Free Cash Flow for 4 consecutive years, with $96.5 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Free Cash Flow rose 200.69% year-over-year to $96.5 million in Q2 2021; TTM through Jun 2021 was $112.7 million, a 28.0% increase from a year earlier, with the FY2025 full-year figure at -$50.5 million, down 374.06% from the prior year.
  • Free Cash Flow was $96.5 million for Q2 2021 at HUTCHMED (China), up from -$16.3 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $96.5 million in Q2 2021 and troughed at -$16.3 million in Q1 2021.
  • A 4-year average of $19.1 million and a median of $12.2 million in 2018 frame the typical range for Free Cash Flow.
  • Across the five-year window, Free Cash Flow soared 2011.86% in 2019 and slumped 5039.09% in 2021, its largest moves.
  • Over 4 years, Free Cash Flow stood at $4.1 million in 2018, then surged by 391.35% to $20.3 million in 2019, then soared by 57.86% to $32.1 million in 2020, then jumped by 200.69% to $96.5 million in 2021.
  • The last three Free Cash Flow figures came in at $96.5 million (Q2 2021), -$16.3 million (Q1 2021), and $32.1 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn 3.49 Bn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn 3.43 Bn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn 1.01 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 572.80 Mn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn -
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn -563.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn 292.04 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn 408.00 Mn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn -268.64 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 96.53 Mn
Mar 31, 2021 -16.30 Mn
Jun 30, 2020 32.10 Mn
Mar 31, 2020 330,000.00
Dec 31, 2019 20.34 Mn
Sep 30, 2019 35.25 Mn
Jun 30, 2019 3.61 Mn
Mar 31, 2019 30.28 Mn
Dec 31, 2018 4.14 Mn
Sep 30, 2018 1.67 Mn
Jun 30, 2018 -11.48 Mn
Mar 31, 2018 32.16 Mn